Tango Therapeutics Inc. (TNGX)
NASDAQ: TNGX
· Real-Time Price · USD
6.79
-0.13 (-1.88%)
At close: Aug 15, 2025, 3:59 PM
6.77
-0.29%
After-hours: Aug 15, 2025, 04:59 PM EDT
Tango Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 24.3M | 40.99M | 42.07M | 43.38M | 42.51M | 37.23M | 36.53M | 37.51M | 33.7M | 24.87M | 24.86M | 24.16M | 24.03M | 36.41M | 37.04M | 40.47M | 22.42M | 9.33M |
Cost of Revenue | 625K | 632K | 1.26M | 1.87M | 2.49M | 3.36M | 4.2M | 5.03M | 5.64M | 4.82M | 4.03M | 24.21M | 44.91M | 63.31M | 77.64M | 71.06M | 62.12M | 54.17M |
Gross Profit | 23.67M | 40.36M | 40.81M | 41.51M | 40.02M | 33.87M | 32.33M | 32.48M | 28.06M | 20.05M | 20.83M | -45K | -20.88M | -26.89M | -40.59M | -30.6M | -39.7M | -44.84M |
Operating Income | -157.28M | -145.87M | -145.59M | -139.7M | -132.45M | -126.14M | -114.17M | -109.73M | -114.02M | -115.98M | -110.68M | -102.1M | -91.75M | -71.1M | -58.19M | -45.14M | -52.33M | -56.22M |
Interest Income | 6.47M | 7.31M | 7.89M | 8.31M | 8.38M | 7.75M | 6.62M | 4.97M | 3.45M | 2.3M | 1.46M | 1.06M | 802K | 609K | 495K | 370K | 279K | 202K |
Pretax Income | -145.39M | -132.06M | -130.09M | -123.19M | -116.32M | -111.48M | -101.61M | -99.9M | -106.71M | -110.92M | -108.12M | -100.98M | -91.46M | -71.12M | -57.94M | -44.94M | -52.21M | -56.09M |
Net Income | -145.57M | -132.26M | -130.3M | -123.39M | -116.49M | -111.65M | -99.47M | -97.76M | -103.68M | -107.83M | -107.13M | -100.12M | -91.53M | -71.17M | -58.23M | -45.05M | -52.27M | -56.16M |
Selling & General & Admin | 45.13M | 44.56M | 43.75M | 41.76M | 39.75M | 38.15M | 35.5M | 34.28M | 33.17M | 31.23M | 30.02M | 28.2M | 24.54M | 20.94M | 17.6M | 14.55M | 12.63M | 11.38M |
Research & Development | 135.82M | 142.3M | 143.92M | 141.32M | 135.21M | 125.22M | 115.2M | 112.95M | 114.55M | 109.61M | 105.91M | 98.45M | 91.63M | 86.97M | 77.64M | 71.06M | 62.12M | 54.17M |
Other Expenses | n/a | n/a | n/a | 2.06M | 3.58M | 6.18M | 8.45M | 7.95M | 6.96M | 4.41M | 2.08M | 641K | 68K | -44K | -52K | -165K | -111K | -49K |
Operating Expenses | 180.96M | 186.86M | 187.66M | 183.08M | 174.96M | 163.37M | 150.7M | 147.23M | 147.72M | 140.85M | 135.93M | 126.65M | 116.17M | 107.9M | 95.23M | 85.61M | 74.75M | 54.4M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 50K | 50K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 181.58M | 186.86M | 187.66M | 183.08M | 174.96M | 163.37M | 150.7M | 147.23M | 147.72M | 140.85M | 135.93M | 126.65M | 116.17M | 107.9M | 95.23M | 85.61M | 74.75M | 65.52M |
Income Tax Expense | 172K | 202K | 208K | 206K | 175K | 174K | -2.14M | -2.14M | -3.04M | -3.1M | -990K | -864K | 71K | 47K | 292K | 115.01K | 103.01K | 124.01K |
Shares Outstanding (Basic) | 110.54M | 110.3M | 108.68M | 108.51M | 108.31M | 108.17M | 97.22M | 97.03M | 88.35M | 88.19M | 87.97M | 87.89M | 87.84M | 87.67M | 87.57M | 70.16M | 87.47M | 87.47M |
Shares Outstanding (Diluted) | 110.54M | 110.3M | 108.68M | 108.51M | 108.31M | 108.17M | 97.22M | 97.03M | 88.35M | 88.19M | 87.97M | 87.89M | 87.84M | 87.67M | 87.57M | 70.16M | 87.47M | 87.47M |
EPS (Basic) | -1.32 | -1.21 | -1.2 | -1.18 | -1.14 | -1.13 | -1.07 | -1.08 | -1.17 | -1.22 | -1.22 | -1.14 | -1.1 | -0.87 | -0.72 | -1 | -1.03 | -1.73 |
EPS (Diluted) | -1.32 | -1.21 | -1.2 | -1.18 | -1.14 | -1.13 | -1.07 | -1.08 | -1.17 | -1.22 | -1.22 | -1.14 | -1.1 | -0.87 | -0.72 | -0.89 | -0.92 | -1.62 |
EBITDA | -152.65M | -143.37M | -143.1M | -137.2M | -129.96M | -123.68M | -111.76M | -107.36M | -111.85M | -114.1M | -109.46M | -101.19M | -91.03M | -70.49M | -57.29M | -44.31M | -51.54M | -55.46M |
EBIT | -155.14M | -145.87M | -145.59M | -139.7M | -132.45M | -126.14M | -114.17M | -109.73M | -114.02M | -115.98M | -111.07M | -102.49M | -92.13M | -71.49M | -58.19M | -45.14M | -52.33M | -56.22M |
Depreciation & Amortization | 2.49M | 2.5M | 2.5M | 2.5M | 2.49M | 3.36M | 4.2M | 5.03M | 5.64M | 4.82M | 4.03M | 3.15M | 2.13M | 1.66M | 1.19M | 807K | 793K | 758K |